{"nct_id":"NCT03828448","title":"Study to Assess Umbralisib Plus Ublituximab in Participants With Treatment Naïve Follicular Lymphoma","status":"TERMINATED","status_verified_date":"2023-07","start_date":"2019-07-10","start_date_type":"ACTUAL","primary_completion_date":"2022-05-16","primary_completion_date_type":"ACTUAL","completion_date":"2022-05-31","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["TGTX"]}